Abstract

Objective To estimate current US herd-level and animal-level prevalence of bovine leukemia virus (BLV) in dairy cows and characterize epidemiologic features. Design Cross-sectional observational study design and survey. Animals 4120 dairy cows from 103 commercial dairy herds in 11 states across the US. Procedures Milk samples were collected from dairy cows through routine commercial sampling and tested for anti-BLV antibodies by antibody capture ELISA. Based on the ELISA results of a sample of an average of 40 cows per herd, within-herd apparent prevalence (AP) was estimated by a directly standardized method and by a lactation-weighted method for each herd. Within-herd AP estimates were summarized to give estimates of US herd-level and animal-level AP. Differences in AP by lactation, region, state, breed, and herd size were examined to characterize basic epidemiologic features of BLV infection. Results 94.2% of herds had at least one BLV antibody positive cow detected. The average within-herd standardized AP was 46.5%. Lactation-specific AP increased with increasing lactation number, from 29.7% in first lactation cows to 58.9% in 4th and greater lactation cows. Significant differences were not observed based on region, state, breed, or herd size. Conclusions and Clinical Relevance These results are consistent with a historical trend of increasing prevalence of BLV among US dairy cattle. Given the findings of other studies on the negative impacts of BLV infection on milk production and cow longevity, these findings are clinically relevant for veterinarians counseling dairy clients on the risks of BLV to their herds.

Highlights

  • Bovine leukemia virus was recognized as the causative agent of enzootic bovine leukosis in the late 1960s and early 1970s [1,2,3,4]

  • A letter of invitation was sent to the designated contact person for the herd, along with an informed consent form authorizing collection of samples and longitudinal collection of production data and a mailed survey of management practices adapted from an in-person interview form which was used in a previous study of risk factors for herd bovine leukemia virus (BLV) prevalence [35]

  • The 1996 NAHMS Dairy Study found that 88.3% of dairy herds had at least one antibody-positive animal, and 40.8% of cows overall were antibody-positive for BLV [7, 8, 12]

Read more

Summary

Introduction

Bovine leukemia virus was recognized as the causative agent of enzootic bovine leukosis in the late 1960s and early 1970s [1,2,3,4]. 19 member states of the European Union, the United Kingdom, New Zealand, and Australia have completely eradicated BLV from their dairy cow populations, and control programs are underway in the remaining member states of the EU resulting in an overall herd prevalence in the EU of less than one percent [11, 22, 23]. Between 2010 and 2012, our research group conducted studies of BLV in 113 Michigan dairy herds using milk ELISA1 testing of a sample of 40 cows in each herd to estimate within-herd AP, which ranged from 0% to 80.6% with an average of 32.8% [9, 33,34,35,36]. ELISA-positive cows in that study were 23% more likely to be culled during the follow-up period, and 2nd

Methods
Results
Discussion
Conclusion
Full Text
Published version (Free)

Talk to us

Join us for a 30 min session where you can share your feedback and ask us any queries you have

Schedule a call